British Journal of Dermatology, 2025
Orismilast, a phosphodiesterase 4B/D inhibitor, in moderate-to-severe atopic dermatitis: efficacy and safety from a multicentre randomized placebo-controlled phase IIb dose-ranging study (ADESOS)

Silverberg J., Eichenfield L., Blauvelt A. et al.

European Heart Journal, 2025
Fibroblast growth factor 5: a novel biomarker for familial hypercholesterolaemia

Baragetti A., Alieva A., Grigore L. et al.

European Heart Journal, 2025
Mosaic loss of Y chromosome and mortality after coronary angiography

Weyrich M., Zewinger S., Sarakpi T. et al.

Journal of Translational Medicine, 2025
Multi-omics analysis reveals novel causal pathways in psoriasis pathogenesis

Guo H., Gao J., Gong L. et al.

European Journal of Preventive Cardiology, 2025
Fibroblast growth factor 23 and outcomes of atrial fibrillation: from clinical association to genetic evidence

Li J., Lai Y., Jiang C. et al.

Biomolecules, 2025
A Genetic and Environmental Analysis of Inflammatory Factors in Chronic Widespread Pain Using the TwinsUK Cohort

Cherny S., Livshits G., Williams F.

Hepatology International, 2025
Non-canonical Wnt signaling pathway activated NFATC3 promotes GDF15 expression in MASH: prospective analyses of UK biobank proteomic data

Wang H., Xu X., Shi L. et al.

European Journal of Heart Failure, 2025
Circulating growth differentiation factor‐15 levels are associated with early echocardiographic signs of diastolic function impairment in the STANISLAS cohort: A 20‐year follow‐up study

Monzo L., Xhaard C., Ferreira J. et al.

Alzheimer's & Dementia: Translational Research & Clinical Interventions, 2025
Unraveling the impact of blood RANKL and OPG levels on Alzheimer's disease: Independent of bone mineral density and inflammation

Guo X., Shi W., Lu J. et al.

Clinical Proteomics, 2025
ARTN and CCL23 predicted chemosensitivity in acute myeloid leukemia: an Olink® proteomics approach

Wu T., Hsiao T., Chen C. et al.

American Journal of Physiology-Heart and Circulatory Physiology, 2025
Chemerin is a new sex-specific target in aortic stenosis concomitant with diabetes regulated by the aldosterone/mineralocorticoid receptor axis

Goñi-Olóriz M., Garaikoetxea Zubillaga M., San Ildefonso-García S. et al.

Cell, 2025
Systems-level immunomonitoring in children with solid tumors to enable precision medicine

Chen Q., Zhao B., Tan Z. et al.

Archives of Gerontology and Geriatrics, 2025
Causal relationship between gut microbiota and ageing: A multi-omics Mendelian randomization study

Zhang G., Lu Y., Wang Z. et al.

Molecular Psychiatry, 2025
Novel synaptic markers predict early tau pathology and cognitive deficit in an asymptomatic population at risk of Alzheimer’s disease

Ao J., Picard C., Auld D. et al.

Cell Death & Disease, 2025
ERG mediates the differentiation of hepatic progenitor cells towards immunosuppressive PDGFRα+ cancer-associated fibroblasts during hepatocarcinogenesis

Bai H., Zhu X., Gao L. et al.

Epilepsy & Behavior, 2025
Butylphthalide may inhibit blood–brain barrier disruption through complement-related pathways to alleviate cognitive impairment in epileptic mice

Zhao L., Chen S., Jin X. et al.

Biological Psychiatry, 2025
MAPPING THE CEREBROSPINAL FLUID PROTEOME IN BIPOLAR DISORDER

Göteson A., Holmén-Larsson J., Celik H. et al.

Alzheimer's & Dementia, 2025
Plasma proteomic biomarkers as mediators or moderators for the association between poor cardiovascular health and white matter microstructural integrity: The UK Biobank study

Beydoun M., Beydoun H., Noren Hooten N. et al.

Epilepsia, 2025
Distinct peripheral pro‐inflammatory profile associated with tuberous sclerosis complex and epilepsy

Balthazard R., Drouin‐Engler R., Bertrand S. et al.

Brain Sciences, 2025
A Pilot Proteomic Analysis of Huntington’s Disease by Functional Capacity

McGarry A., Moaddel R.